{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:06:43Z","timestamp":1794604003447,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:00:00Z","timestamp":1301529600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diagnostic accuracy of lymphoma, a heterogeneous cancer, is essential for patient management. Several ancillary tests including immunophenotyping, and sometimes cytogenetics and PCR are required to aid histological diagnosis. In this proof of principle study, gene expression microarray was evaluated as a single platform test in the differential diagnosis of common lymphoma subtypes and reactive lymphadenopathy (RL) in lymph node biopsies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>116 lymph node biopsies diagnosed as RL, classical Hodgkin lymphoma (cHL), diffuse large B cell lymphoma (DLBCL) or follicular lymphoma (FL) were assayed by mRNA microarray. Three supervised classification strategies (global multi-class, local binary-class and global binary-class classifications) using diagonal linear discriminant analysis was performed on training sets of array data and the classification error rates calculated by leave one out cross-validation. The independent error rate was then evaluated by testing the identified gene classifiers on an independent (test) set of array data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The binary classifications provided prediction accuracies, between a subtype of interest and the remaining samples, of 88.5%, 82.8%, 82.8% and 80.0% for FL, cHL, DLBCL, and RL respectively. Identified gene classifiers include LIM domain only-2 (<jats:italic>LMO2<\/jats:italic>), Chemokine (C-C motif) ligand 22 (<jats:italic>CCL22<\/jats:italic>) and Cyclin-dependent kinase inhibitor-3 (<jats:italic>CDK3<\/jats:italic>) specifically for FL, cHL and DLBCL subtypes respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study highlights the ability of gene expression profiling to distinguish lymphoma from reactive conditions and classify the major subtypes of lymphoma in a diagnostic setting. A cost-effective single platform \"mini-chip\" assay could, in principle, be developed to aid the quick diagnosis of lymph node biopsies with the potential to incorporate other pathological entities into such an assay.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1755-8794-4-27","type":"journal-article","created":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T18:17:20Z","timestamp":1302113840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling"],"prefix":"10.1186","volume":"4","author":[{"given":"To Ha","family":"Loi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Campain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lutherborrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Hwa Jean","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David DF","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,31]]},"reference":[{"key":"222_CR1","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, (Eds): WHO Classification of Tumours of Haematopoietic and Lymphoid tissue. 2008, Lyon: IARC"},{"key":"222_CR2","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, et al: Molecular diagnosis of Burkitt's lymphoma. N Engl J Med. 2006, 354: 2431-2442. 10.1056\/NEJMoa055759.","journal-title":"N Engl J Med"},{"key":"222_CR3","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","volume":"102","author":"KJ Savage","year":"2003","unstructured":"Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, Kurtin P, Dal Cin P, Ladd C, Feuerhake F, et al: The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003, 102: 3871-3879. 10.1182\/blood-2003-06-1841.","journal-title":"Blood"},{"key":"222_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000, 403: 503-511. 10.1038\/35000501.","journal-title":"Nature"},{"key":"222_CR5","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002, 346: 1937-1947. 10.1056\/NEJMoa012914.","journal-title":"N Engl J Med"},{"key":"222_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van't Veer","year":"2002","unstructured":"van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002, 415: 530-536.","journal-title":"Nature"},{"key":"222_CR7","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1073\/pnas.96.12.6745","volume":"96","author":"U Alon","year":"1999","unstructured":"Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, Levine AJ: Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA. 1999, 96: 6745-6750. 10.1073\/pnas.96.12.6745.","journal-title":"Proc Natl Acad Sci USA"},{"key":"222_CR8","first-page":"5974","volume":"61","author":"JB Welsh","year":"2001","unstructured":"Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF, Hampton GM: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 2001, 61: 5974-5978.","journal-title":"Cancer Res"},{"key":"222_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S1525-1578(10)60547-8","volume":"7","author":"AN Schuetz","year":"2005","unstructured":"Schuetz AN, Yin-Goen Q, Amin MB, Moreno CS, Cohen C, Hornsby CD, Yang WL, Petros JA, Issa MM, Pattaras JG, et al: Molecular classification of renal tumors by gene expression profiling. J Mol Diagn. 2005, 7: 206-218. 10.1016\/S1525-1578(10)60547-8.","journal-title":"J Mol Diagn"},{"key":"222_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/annonc\/mdh140","volume":"15","author":"JJ Turner","year":"2004","unstructured":"Turner JJ, Hughes AM, Kricker A, Milliken S, Grulich A, Kaldor J, Armstrong B: Use of the WHO lymphoma classification in a population-based epidemiological study. Ann Oncol. 2004, 15: 631-637. 10.1093\/annonc\/mdh140.","journal-title":"Ann Oncol"},{"key":"222_CR11","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW, (Eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. 2001, Lyon: IARC Press"},{"key":"222_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, et al: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004, 103: 275-282. 10.1182\/blood-2003-05-1545.","journal-title":"Blood"},{"key":"222_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/0-387-29362-0_4","volume-title":"Bioinformatics and Computational Biology Solutions using R and Bioconductor","author":"YH Yang","year":"2005","unstructured":"Yang YH, Pacquet AC: Preprocessing Two-Colour Spotted Arrays. Bioinformatics and Computational Biology Solutions using R and Bioconductor. Edited by: Gentleman R, Carey V, Dudoit S, Irizarry RA, Huber W. 2005, New York: Sprinter, 49-70. full_text."},{"key":"222_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1365-2141.2006.06266.x","volume":"135","author":"L Belov","year":"2006","unstructured":"Belov L, Mulligan SP, Barber N, Woolfson A, Scott M, Stoner K, Chrisp JS, Sewell WA, Bradstock KF, Bendall L, et al: Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray. Br J Haematol. 2006, 135: 184-197. 10.1111\/j.1365-2141.2006.06266.x.","journal-title":"Br J Haematol"},{"key":"222_CR15","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/bioinformatics\/btg182","volume":"19","author":"RL Somorjai","year":"2003","unstructured":"Somorjai RL, Dolenko B, Baumgartner R: Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions. Bioinformatics. 2003, 19: 1484-1491. 10.1093\/bioinformatics\/btg182.","journal-title":"Bioinformatics"},{"key":"222_CR16","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","volume":"105","author":"S Monti","year":"2005","unstructured":"Monti S, Savage KJ, Kutok JL, Feuerhake F, Kurtin P, Mihm M, Wu B, Pasqualucci L, Neuberg D, Aguiar RC, et al: Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood. 2005, 105: 1851-1861. 10.1182\/blood-2004-07-2947.","journal-title":"Blood"},{"key":"222_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nm0102-68","volume":"8","author":"MA Shipp","year":"2002","unstructured":"Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, et al: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002, 8: 68-74. 10.1038\/nm0102-68.","journal-title":"Nat Med"},{"key":"222_CR18","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1182\/blood-2008-02-137372","volume":"112","author":"LM Rimsza","year":"2008","unstructured":"Rimsza LM, Leblanc ML, Unger JM, Miller TP, Grogan TM, Persky DO, Martel RR, Sabalos CM, Seligmann B, Braziel RM, et al: Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2008, 112: 3425-3433. 10.1182\/blood-2008-02-137372.","journal-title":"Blood"},{"key":"222_CR19","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","volume":"13","author":"CH Lawrie","year":"2009","unstructured":"Lawrie CH, Chi J, Taylor S, Tramonti D, Ballabio E, Palazzo S, Saunders NJ, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS: Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med. 2009, 13: 1248-1260. 10.1111\/j.1582-4934.2008.00628.x.","journal-title":"J Cell Mol Med"},{"key":"222_CR20","volume-title":"Clin Chem","author":"M Jung","year":"2010","unstructured":"Jung M, Schaefer A, Steiner I, Kempkensteffen C, Stephan C, Erbersdobler A, Jung K: Robust MicroRNA Stability in Degraded RNA Preparations from Human Tissue and Cell Samples. Clin Chem. 2010, 56: 10.1373\/clinchem.2009.141580."},{"key":"222_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/bioinformatics\/bth469","volume":"21","author":"L Ein-Dor","year":"2005","unstructured":"Ein-Dor L, Kela I, Getz G, Givol D, Domany E: Outcome signature genes in breast cancer: is there a unique set?. Bioinformatics. 2005, 21: 171-178. 10.1093\/bioinformatics\/bth469.","journal-title":"Bioinformatics"},{"key":"222_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/cyto.b.20459","volume":"76","author":"AC Seegmiller","year":"2009","unstructured":"Seegmiller AC, Karandikar NJ, Kroft SH, McKenna RW, Xu Y: Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytes. Cytometry B Clin Cytom. 2009, 76: 169-174.","journal-title":"Cytometry B Clin Cytom"},{"key":"222_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2141.2007.06964.x","volume":"140","author":"M Niens","year":"2008","unstructured":"Niens M, Visser L, Nolte IM, van der Steege G, Diepstra A, Cordano P, Jarrett RF, Te Meerman GJ, Poppema S, van den Berg A: Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22. Br J Haematol. 2008, 140: 527-536. 10.1111\/j.1365-2141.2007.06964.x.","journal-title":"Br J Haematol"},{"key":"222_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.pathol.4.110807.092209","volume":"4","author":"R Schmitz","year":"2009","unstructured":"Schmitz R, Stanelle J, Hansmann ML, Kuppers R: Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol. 2009, 4: 151-174. 10.1146\/annurev.pathol.4.110807.092209.","journal-title":"Annu Rev Pathol"},{"key":"222_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1182\/blood-2005-12-5125","volume":"108","author":"A Sanchez-Aguilera","year":"2006","unstructured":"Sanchez-Aguilera A, Montalban C, de la Cueva P, Sanchez-Verde L, Morente MM, Garcia-Cosio M, Garcia-Larana J, Bellas C, Provencio M, Romagosa V, et al: Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood. 2006, 108: 662-668. 10.1182\/blood-2005-12-5125.","journal-title":"Blood"},{"key":"222_CR26","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","volume":"106","author":"P Farinha","year":"2005","unstructured":"Farinha P, Masoudi H, Skinnider BF, Shumansky K, Spinelli JJ, Gill K, Klasa R, Voss N, Connors JM, Gascoyne RD: Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood. 2005, 106: 2169-2174. 10.1182\/blood-2005-04-1565.","journal-title":"Blood"},{"key":"222_CR27","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1182\/blood-2006-08-039024","volume":"109","author":"Y Natkunam","year":"2007","unstructured":"Natkunam Y, Zhao S, Mason DY, Chen J, Taidi B, Jones M, Hammer AS, Hamilton Dutoit S, Lossos IS, Levy R: The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood. 2007, 109: 1636-1642. 10.1182\/blood-2006-08-039024.","journal-title":"Blood"},{"key":"222_CR28","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1056\/NEJMoa032520","volume":"350","author":"IS Lossos","year":"2004","unstructured":"Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, Levy R: Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 2004, 350: 1828-1837. 10.1056\/NEJMoa032520.","journal-title":"N Engl J Med"},{"key":"222_CR29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/117693510700300004","volume":"3","author":"S Blenk","year":"2007","unstructured":"Blenk S, Engelmann J, Weniger M, Schultz J, Dittrich M, Rosenwald A, Muller-Hermelink HK, Muller T, Dandekar T: Germinal Center B Cell-Like (GCB) and Activated B Cell-Like (ABC) Type of Diffuse Large B Cell Lymphoma (DLBCL): Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival. Cancer Inform. 2007, 3: 399-420.","journal-title":"Cancer Inform"},{"key":"222_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2199-9-57","volume":"9","author":"O Bereczki","year":"2008","unstructured":"Bereczki O, Ujfaludi Z, Pardi N, Nagy Z, Tora L, Boros IM, Balint E: TATA binding protein associated factor 3 (TAF3) interacts with p53 and inhibits its function. BMC Mol Biol. 2008, 9: 57-10.1186\/1471-2199-9-57.","journal-title":"BMC Mol Biol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1755-8794-4-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1755-8794-4-27\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1755-8794-4-27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1755-8794-4-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:43:59Z","timestamp":1630503839000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/1755-8794-4-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,31]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1186\/1755-8794-4-27","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,31]]},"assertion":[{"value":"28 July 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}